“…VCAM-1 can also be released from the endothelial surface through cleavage by a disintegrin and metalloprotease 17 (ADAM17) (97) and, although less characterized, may be released by ADAM8 (185,186) or ADAM9 (103,222). Therefore, VCAM-1 is present in the plasma in a soluble form (sVCAM-1) and is used as predictive biomarker of disease (17,127,154,297,319). Levels of sVCAM-1 in plasma increase with activation of the endothelium in multiple diseases (44,55,89,98,133,154,206,219,227).…”